LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients allergic to standard drugs
Disease control NO_LONGER_AVAILABLEThis study provided an alternative medication called Erwinase to patients with acute lymphoblastic leukemia (ALL) who had allergic reactions to standard treatments. It was designed for people who developed rashes or severe reactions to other forms of the drug L-asparaginase. The …
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for tough leukemia: targeted drug combo trial
Disease control OngoingThis study is testing if adding a targeted drug called ponatinib to standard chemotherapy works better for adults with a specific, aggressive type of acute lymphoblastic leukemia (ALL). It aims to see if this combination can drive the cancer into deep remission, measured by a sen…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC